Showing results (1721-1730 of 4,056) with videos related to
Sort By:
Pageof 406
Translational Cancer Research|June 17, 2024
Identification of PRODH as a mitochondria- and angiogenesis-related biomarker for lung adenocarcinomaXinran Xi, Meng Zhang, Yonghua Li, et al.Translational Cancer Research|June 17, 2024
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteriaMarvin Okon, Joel Williams, Khoa Truong, et al.Translational Cancer Research|June 17, 2024
Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma: a case report of a possible abscopal effectSara Elena Campos Ramírez, María Carmen Gómez Mateo, Sofía Elena Ruffini Egea, et al.Translational Cancer Research|June 17, 2024
Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 (ADCY2) in tumorigenesis and prognosisHaojue Wang, Weihan Luo, Jin Ji, et al.Translational Cancer Research|June 17, 2024
Molecular mechanism of RBM14-mediated promotion of proliferation, migration, and invasion in osteosarcomaSijian Lin, Jiachao Xiong, Faxin Zhou, et al.Translational Cancer Research|May 13, 2024
Identification of immune-related prognostic biomarkers in triple-negative breast cancerXiao-Qing Song, Zhi-Ming ShaoTranslational Cancer Research|May 13, 2024
An innovative prognostic auxiliary for colon adenocarcinoma based on zinc finger protein genesFan Xu, Jiahui Sun, Xinyue Gu, et al.Translational Cancer Research|May 13, 2024
Association between human epidermal growth factor receptor 2 status, namely low and zero expression, and prognosis in hormone receptor-positive breast cancer: a single-center retrospective studyYuki Hara, Hiroshi Yano, Yuka Ishida, et al.Translational Cancer Research|May 13, 2024
Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA databaseJun-Yan He, Zhi-Min Li, Ya-Ting Chen, et al.Translational Cancer Research|April 15, 2024
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 casesXuexia Liang, Yanhui Jiang, Wei Yao, et al.Pageof 406